Adaptimmune Aims To Quickly Convert Teclera’s Accelerated Approval

 
• By Bridget Silverman
building under construction
Adaptimmune plans to fill out its Teclera label with confirmatory evidence to be submitted 2025. • Source: Shutterstock

More from Approvals

More from Product Reviews